MVASI 100 mg/4 ml
MVASI 100 mg/4 ml is a medicine authorised by Swissmedic under authorisation number 67283. The authorisation holder is Amgen Switzerland AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 09 December 2019 and the authorisation is valid without a time limit. ATC code L01FG01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67283 |
|---|---|
| Name | MVASI 100 mg/4 ml |
| Full name | MVASI 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Amgen Switzerland AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FG01 |
| First authorisation | 09 December 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | MVASI 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 09 December 2019 |
| 2 | MVASI 400 mg/16 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 09 December 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FG01 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01FG01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is MVASI 100 mg/4 ml authorised in Switzerland?
Yes. MVASI 100 mg/4 ml is authorised by Swissmedic under authorisation number 67283, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does MVASI 100 mg/4 ml have?
MVASI 100 mg/4 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of MVASI 100 mg/4 ml?
The authorisation holder is Amgen Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.